Evaluation and management of pulmonary arterial hypertension.

Genetics Patient perspectives Pulmonary arterial hypertension Pulmonary hypertension Risk stratification Treatment

Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
09 2020
Historique:
received: 06 07 2020
accepted: 26 07 2020
pubmed: 24 8 2020
medline: 18 5 2021
entrez: 24 8 2020
Statut: ppublish

Résumé

Pulmonary arterial hypertension is a devastating progressive disease mediated by different pathophysiologic pathways that result in progressive increase in pulmonary vascular resistance along with right ventricular failure and eventually premature death. Despite significant advances in the understanding of the underlying mechanisms and development of a number of targeted therapies, pulmonary arterial hypertension remains a challenging condition with high morbidity and mortality. New therapies are being actively sought, and early recognition remains of paramount importance. In an effort to improve the detection and management of pulmonary hypertension, the 6th World Symposium on Pulmonary Hypertension came up with most recent statements in 2018. The goal of this review is to summarize some key updates from the proceedings of the Symposium pertaining to different aspects of evaluation and management of patients with pulmonary arterial hypertension.

Identifiants

pubmed: 32829182
pii: S0954-6111(20)30239-0
doi: 10.1016/j.rmed.2020.106099
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106099

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Sarah Beshay (S)

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Houston Methodist Hospital, Houston, TX, USA.

Sandeep Sahay (S)

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Houston Methodist Hospital, Houston, TX, USA. Electronic address: ssahay@houstonmethodist.org.

Marc Humbert (M)

Université Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France; Assistance Publique - Hôpitaux de Paris, Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH